C. David Weaver

5.4k citations
125 papers · 4.1k · h-index 39

Impact in

  • Cellular and Molecular Neuroscience top 0.5%
    • Neuroscience and Neuropharmacology Research
    • Neuropeptides and Animal Physiology
    • Photoreceptor and optogenetics research
  • Molecular Biology top 2%
    • Receptor Mechanisms and Signaling
    • Ion channel regulation and function
    • Nicotinic Acetylcholine Receptors Study
    • Ion Transport and Channel Regulation

Papers in

  • Molecular Biology 94
    • Ion channel regulation and function 46
    • Receptor Mechanisms and Signaling 37
    • Pharmacological Receptor Mechanisms and Effects 12
    • Nicotinic Acetylcholine Receptors Study 7
  • Cellular and Molecular Neuroscience 67
    • Neuroscience and Neuropharmacology Research 50
    • Neuropeptides and Animal Physiology 9
Co-authors
Craig W. Lindsley (58 shared papers)Daniel M. Roberts (5 shared papers)P. Jeffrey Conn (30 shared papers)Colleen M. Niswender (30 shared papers)Emily Days (24 shared papers)Jerod S. Denton (16 shared papers)Carrie K. Jones (18 shared papers)L. Michelle Lewis (18 shared papers)
Journals
Bioorganic & Medicinal Chemistry Letters (16 papers)Molecular Pharmacology (13 papers)ACS Chemical Neuroscience (12 papers)Journal of Medicinal Chemistry (10 papers)Journal of Biological Chemistry (8 papers)
Partner nations
United StatesGermanyUnited Kingdom

In The Last Decade

C. David Weaver

121 papers receiving 4.0k citations

Peers

C. David Weaver
Comparison fields: 5 of 125
  • Cellular and Molecular Neuroscience 2.1k
  • Molecular Biology 2.7k
  • Sensory Systems 176
  • Physiology 79
  • Cardiology and Cardiovascular Medicine 329
Replace Wolfgang Jarolimek with:
Wolfgang Jarolimek Australia
Jin‐Sung Choi South Korea
Frederick J. Ehlert United States
Steffen Hering Austria
Heinz Bönisch Germany
Sergio Bova Italy
Esam E. El‐Fakahany United States
Gary J. Stephens United Kingdom
Leigh D. Plant United States
Francesco Clementi Italy
C. David Weaver relative to Wolfgang Jarolimek Australia Wolfgang Jarolimek's profile →
Citations per field
00.5×1.5×2.1×
Wolfgang Jarolimek · 1×
Citations per year

Countries citing papers authored by C. David Weaver

Since Specialization
Citations

This map shows the geographic impact of C. David Weaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. David Weaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. David Weaver more than expected).

Fields of papers citing papers by C. David Weaver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. David Weaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. David Weaver. The network helps show where C. David Weaver may publish in the future.

Co-authors

The 25 scholars most cited alongside C. David Weaver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. David Weaver Line = papers co-authored together C. David Weaver links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Identification of ML204, a Novel Potent Antagonist That Selectively Modulates Native TRPC4/C5 Ion Channels
Journal of Biological Chemistry ·Melissa Miller, Jie Shi, Yingmin Zhu, Maksym Kustov, Jinbin Tian, Amy O. Stevens, Meng Wu, Jia Xu, Shunyou Long, Yang Pu, Alexander V. Zholos, James M. Salovich, C. David Weaver, Corey R. Hopkins, Craig W. Lindsley, Owen B. McManus, Min Li, Michael X. Zhu
2011178
2
Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4
Molecular Pharmacology ·Colleen M. Niswender, Kari A. Johnson, C. David Weaver, Carrie K. Jones, Zixiu Xiang, Qingwei Luo, Alice L. Rodriguez, Joy E. Marlo, Tomas de Paulis, Analisa D. Thompson, Emily Days, Tasha Nalywajko, Cheryl A. Austin, Michael Baxter Williams, Jennifer Ayala, Richard D. Williams, Craig W. Lindsley, P. Jeffrey Conn
2008161
3
Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity
Molecular Pharmacology ·Alice L. Rodriguez, Mark D. Grier, Carrie K. Jones, Elizabeth J. Herman, Alexander S. Kane, Randy L. Smith, Richard D. Williams, Ya Zhou, Joy E. Marlo, Emily Days, Tasha N. Blatt, Satyawan Jadhav, Usha N. Menon, Paige N. Vinson, Jerri M. Rook, Shaun R. Stauffer, Colleen M. Niswender, Craig W. Lindsley, C. David Weaver, P. Jeffrey Conn
2010147
4
A Thallium-Sensitive, Fluorescence-Based Assay for Detecting and Characterizing Potassium Channel Modulators in Mammalian Cells
SLAS DISCOVERY ·C. David Weaver, David Harden, Steven I. Dworetzky, Barbara Robertson, Ronald J. Knox
2004134
5
ML297 (VU0456810), the First Potent and Selective Activator of the GIRK Potassium Channel, Displays Antiepileptic Properties in Mice
ACS Chemical Neuroscience ·Kristian Kaufmann, Ian M. Romaine, Emily Days, Conrado Pascual, A. Malik, Liya Yang, Bende Zou, Yu Du, Greg Sliwoski, Ryan D. Morrison, Jerod S. Denton, Colleen M. Niswender, J. Scott Daniels, Gary A. Sulikowski, Xinmin Xie, Craig W. Lindsley, C. David Weaver
2013125
6
Discovery and Characterization of Novel Allosteric Potentiators of M1 Muscarinic Receptors Reveals Multiple Modes of Activity
Molecular Pharmacology ·Joy E. Marlo, Colleen M. Niswender, Emily Days, Thomas M. Bridges, Yun Xiang, Alice L. Rodriguez, Jana K. Shirey, Ashley E. Brady, Tasha Nalywajko, Qingwei Luo, Cheryl A. Austin, Michael Baxter Williams, Kwangho Kim, Richard D. Williams, Darren Orton, H. Alex Brown, Craig W. Lindsley, C. David Weaver, P. Jeffrey Conn
2008119
7
Small-molecule screen identifies inhibitors of the neuronal K-Cl cotransporter KCC2
Proceedings of the National Academy of Sciences ·Eric Delpire, Emily Days, L. Michelle Lewis, Dehui Mi, Kwangho Kim, Craig W. Lindsley, C. David Weaver
2009114
8
Calcium-Dependent Phosphorylation of Symbiosome Membrane Proteins from Nitrogen-Fixing Soybean Nodules
PLANT PHYSIOLOGY ·C. David Weaver, Burnette N. Crombie, Gary Stacey, Daniel M. Roberts
1991101
9
Functional Impact of Allosteric Agonist Activity of Selective Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 in Regulating Central Nervous System Function
Molecular Pharmacology ·Meredith J. Noetzel, Jerri M. Rook, Paige N. Vinson, Hyekyung P. Cho, Emily Days, Ying Zhou, Alice L. Rodriguez, Hilde Lavreysen, Shaun R. Stauffer, Colleen M. Niswender, Zixiu Xiang, J. Scott Daniels, Carrie K. Jones, Craig W. Lindsley, C. David Weaver, P. Jeffrey Conn
201199
10
Nodulin 26, a nodule-specific symbiosome membrane protein from soybean, is an ion channel.
Journal of Biological Chemistry ·C. David Weaver, Nirah H. Shomer, Charles F. Louis, Daniel M. Roberts
199497
11
Differential Expression of Glutamate Receptor Subtypes in Rat Pancreatic Islets
Journal of Biological Chemistry ·C. David Weaver, Tom L. Yao, Alvin C. Powers, Todd A. Verdoorn
199695
12
A Novel Assay of Gi/o-Linked G Protein-Coupled Receptor Coupling to Potassium Channels Provides New Insights into the Pharmacology of the Group III Metabotropic Glutamate Receptors
Molecular Pharmacology ·Colleen M. Niswender, Kari A. Johnson, Qingwei Luo, Jennifer Ayala, Caroline Kim, P. Jeffrey Conn, C. David Weaver
200892
13
Discovery of the First Highly M5-Preferring Muscarinic Acetylcholine Receptor Ligand, an M5 Positive Allosteric Modulator Derived from a Series of 5-Trifluoromethoxy N -Benzyl Isatins
Journal of Medicinal Chemistry ·Thomas M. Bridges, Joy E. Marlo, Colleen M. Niswender, Carrie K. Jones, Satyawan Jadhav, Patrick R. Gentry, Hyekyung C. Plumley, C. David Weaver, P. Jeffrey Conn, Craig W. Lindsley
200988
14
Mechanisms underlying the activation of G-protein–gated inwardly rectifying K+(GIRK) channels by the novel anxiolytic drug, ML297
Proceedings of the National Academy of Sciences ·Nicole Wydeven, Ezequiel Marrón Fernández de Velasco, Yu Du, Michael A. Benneyworth, Matthew C. Hearing, Rachel A. Fischer, Mark J. Thomas, C. David Weaver, Kevin Wickman
201486
15
Sign Inversion in Photopharmacology: Incorporation of Cyclic Azobenzenes in Photoswitchable Potassium Channel Blockers and Openers
Angewandte Chemie International Edition ·Julie B. Trads, Katharina Hüll, Bryan S. Matsuura, Laura Laprell, Timm Fehrentz, Nicole Görldt, Krystian A. Kozek, C. David Weaver, Nikolaj Klöcker, David M. Barber, Dirk Trauner
201980
16
Discovery and Characterization of Novel Subtype-Selective Allosteric Agonists for the Investigation of M1 Receptor Function in the Central Nervous System
ACS Chemical Neuroscience ·Evan P. Lebois, Thomas M. Bridges, L. Michelle Lewis, Eric S. Dawson, Alexander S. Kane, Zixiu Xiang, Satyawan Jadhav, Huiyong Yin, J. Phillip Kennedy, Jens Meiler, Colleen M. Niswender, Carrie K. Jones, P. Jeffrey Conn, C. David Weaver, Craig W. Lindsley
200980
17
Determination of the site of phosphorylation of nodulin 26 by the calcium-dependent protein kinase from soybean nodules
Biochemistry ·C. David Weaver, Daniel M. Roberts
199276
18
A biased ligand for OXE-R uncouples Gα and Gβγ signaling within a heterotrimer
Nature Chemical Biology ·Stefanie Blättermann, Lucas Peters, Philipp A. Ottersbach, Andreas Böck, Viktória Kónya, C. David Weaver, Ángel González, R Schröder, Rahul Tyagi, Petra Luschnig, Jürgen Gäb, Stephanie Hennen, Trond Ulven, Leonardo Pardo, Klaus Mohr, Michael Gütschow, Ákos Heinemann, Evi Kostenis
201271
19
High-Throughput Screening Reveals a Small-Molecule Inhibitor of the Renal Outer Medullary Potassium Channel and Kir7.1
Molecular Pharmacology ·L. Michelle Lewis, Gautam Bhave, Brian A. Chauder, Sreedatta Banerjee, Katharina A. Lornsen, Rey Redha, Katherine Fallen, Craig W. Lindsley, C. David Weaver, Jerod S. Denton
200971
20
Further optimization of the K-Cl cotransporter KCC2 antagonist ML077: Development of a highly selective and more potent in vitro probe
Bioorganic & Medicinal Chemistry Letters ·Eric Delpire, Aleksandra Baranczak, Alex G. Waterson, Kwangho Kim, Nathan R. Kett, Ryan D. Morrison, J. Scott Daniels, C. David Weaver, Craig W. Lindsley
201268

About C. David Weaver

C. David Weaver is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Cardiology and Cardiovascular Medicine, Materials Chemistry and Organic Chemistry, having authored 125 papers that have together received 4.1k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (50 papers), Ion channel regulation and function (46 papers), Receptor Mechanisms and Signaling (37 papers), Cardiac electrophysiology and arrhythmias (22 papers), Pharmacological Receptor Mechanisms and Effects (12 papers), Neuropeptides and Animal Physiology (9 papers), Photochromic and Fluorescence Chemistry (7 papers) and Nicotinic Acetylcholine Receptors Study (7 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.1k citations), Molecular Biology (2.7k citations), Sensory Systems (176 citations), Physiology (79 citations) and Cardiology and Cardiovascular Medicine (329 citations). C. David Weaver has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Craig W. Lindsley, Daniel M. Roberts, P. Jeffrey Conn, Colleen M. Niswender, Emily Days, Jerod S. Denton, Carrie K. Jones, L. Michelle Lewis, Alice L. Rodriguez and Corey R. Hopkins. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Molecular Pharmacology, ACS Chemical Neuroscience, Journal of Medicinal Chemistry and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wolfgang JarolimekBreakdown of academic impact, for papers by Jin‐Sung ChoiBreakdown of academic impact, for papers by Frederick J. EhlertBreakdown of academic impact, for papers by Steffen HeringBreakdown of academic impact, for papers by Heinz BönischBreakdown of academic impact, for papers by Sergio BovaBreakdown of academic impact, for papers by Esam E. El‐FakahanyBreakdown of academic impact, for papers by Gary J. StephensBreakdown of academic impact, for papers by Leigh D. PlantBreakdown of academic impact, for papers by Francesco Clementi